These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 15169804)

  • 1. Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome.
    Grigsby PW; Siegel BA; Dehdashti F; Rader J; Zoberi I
    J Clin Oncol; 2004 Jun; 22(11):2167-71. PubMed ID: 15169804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic FDG uptake in patients with NAFLD: An important prognostic factor for cardio-cerebrovascular events?
    Dimitriu-Leen AC; Scholte AJHA
    J Nucl Cardiol; 2017 Jun; 24(3):900-902. PubMed ID: 26728014
    [No Abstract]   [Full Text] [Related]  

  • 3. Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma.
    Schwarz JK; Siegel BA; Dehdashti F; Grigsby PW
    JAMA; 2007 Nov; 298(19):2289-95. PubMed ID: 18029833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [F18]FDG PET/CT-Derived Metabolic and Volumetric Biomarkers Can Predict Response to Treatment in Locally Advanced Cervical Cancer Patients.
    Gill R; Abdah-Bortnyak R; Amit A; Bar-Peled U; Keidar Z
    Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging Biomarkers and Liquid Biopsy in Assessment of Cervical Cancer.
    Ghani MA; Liau J; Eskander R; Mell L; Yusufaly T; Obrzut S
    J Comput Assist Tomogr; 2022 Sep-Oct 01; 46(5):707-715. PubMed ID: 35995483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative imaging of uterine cancers with diffusion-weighted MRI and 18-fluorodeoxyglucose PET/CT.
    Sertic M; Kilcoyne A; Catalano OA; Lee SI
    Abdom Radiol (NY); 2022 Sep; 47(9):3174-3188. PubMed ID: 34302185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staging, recurrence and follow-up of uterine cervical cancer using MRI: Updated Guidelines of the European Society of Urogenital Radiology after revised FIGO staging 2018.
    Manganaro L; Lakhman Y; Bharwani N; Gui B; Gigli S; Vinci V; Rizzo S; Kido A; Cunha TM; Sala E; Rockall A; Forstner R; Nougaret S
    Eur Radiol; 2021 Oct; 31(10):7802-7816. PubMed ID: 33852049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial Intelligence for Response Evaluation With PET/CT.
    Wei L; El Naqa I
    Semin Nucl Med; 2021 Mar; 51(2):157-169. PubMed ID: 33509372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive Role of MRI and
    Perrone AM; Dondi G; Coe M; Ferioli M; Telo S; Galuppi A; Crescenzo E; Tesei M; Castellucci P; Nanni C; Fanti S; Morganti AG; De Iaco P
    Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32178252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of posttreatment
    Lima GM; Matti A; Vara G; Dondi G; Naselli N; De Crescenzo EM; Morganti AG; Perrone AM; De Iaco P; Nanni C; Fanti S
    Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2139-2146. PubMed ID: 30069578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Study of Positron Emission Tomography/Computed Tomography and Computed Tomography in the Evaluation of Post-treatment Carcinoma Cervix Patients.
    Pantola S; Kala S; Kala C; Sampath S; Shukla M
    Indian J Nucl Med; 2018; 33(3):194-201. PubMed ID: 29962714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glut-1 expression in small cervical biopsies is prognostic in cervical cancers treated with chemoradiation.
    Kanjanapan Y; Deb S; Young RJ; Bressel M; Mileshkin L; Rischin D; Hofman MS; Narayan K; Siva S
    Clin Transl Radiat Oncol; 2017 Feb; 2():53-58. PubMed ID: 29658001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What's New in Imaging for Gynecologic Cancer?
    Khan SR; Arshad M; Wallitt K; Stewart V; Bharwani N; Barwick TD
    Curr Oncol Rep; 2017 Nov; 19(12):85. PubMed ID: 29105030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a serum-induced transcriptional signature associated with metastatic cervical cancer.
    Palatnik A; Ye S; Kendziorski C; Iden M; Zigman JS; Hessner MJ; Rader JS
    PLoS One; 2017; 12(8):e0181242. PubMed ID: 28854209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of
    Narayanan P; Sahdev A
    Br J Radiol; 2017 Nov; 90(1079):20170283. PubMed ID: 28830238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET Radiomics in NSCLC: state of the art and a proposal for harmonization of methodology.
    Sollini M; Cozzi L; Antunovic L; Chiti A; Kirienko M
    Sci Rep; 2017 Mar; 7(1):358. PubMed ID: 28336974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiotherapy response evaluation using FDG PET-CT-established and emerging applications.
    Cliffe H; Patel C; Prestwich R; Scarsbrook A
    Br J Radiol; 2017 Mar; 90(1071):20160764. PubMed ID: 28008773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging radiation response in tumor and normal tissue.
    Rafat M; Ali R; Graves EE
    Am J Nucl Med Mol Imaging; 2015; 5(4):317-32. PubMed ID: 26269771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ¹⁸F-FDG PET/CT following chemoradiation of uterine cervix cancer provides powerful prognostic stratification independent of HPV status: a prospective cohort of 105 women with mature survival data.
    Siva S; Deb S; Young RJ; Hicks RJ; Callahan J; Bressel M; Mileshkin L; Rischin D; Bernshaw D; Narayan K
    Eur J Nucl Med Mol Imaging; 2015 Nov; 42(12):1825-32. PubMed ID: 26173619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-fluorodeoxyglucose positron emission tomography for predicting tumor response to radiochemotherapy in nasopharyngeal carcinoma.
    Su M; Zhao L; Wei H; Lin R; Zhang X; Zou C
    Strahlenther Onkol; 2015 Aug; 191(8):642-8. PubMed ID: 25981635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.